Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study
Bo Langhoff Hønge1, Sanne Jespersen1, Candida Medina2
1Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau; Department of Infectious Diseases, Aarhus University Hospital, Brendstrupgaardsvej 100, 8200 Aarhus, Denmark.
Insights
Hepatitis C virus (HCV) infection is uncommon in HIV-infected patients in Bissau, Guinea-Bissau. Age over 50 was linked to HCV antibodies, with genotype 2 being prevalent.
Area of Science:
- Infectious Diseases
- Hepatology
- Virology
Background:
- Hepatitis C virus (HCV) co-infection is a significant concern in human immunodeficiency virus (HIV)-infected populations.
- Understanding the prevalence and characteristics of HCV in specific geographic regions, like Bissau, Guinea-Bissau, is crucial for public health strategies.
Purpose of the Study:
- To determine the prevalence of HCV infection among HIV-infected individuals in Bissau, Guinea-Bissau.
- To identify clinical, biochemical, and demographic risk factors associated with HCV infection in this population.
Main Methods:
- A cross-sectional study involving 576 HIV-infected patients (HIV-1, HIV-2, and HIV-1/2) was conducted.
- HCV antibodies (anti-HCV), viral load, and genotype were assessed using serological tests and real-time PCR.
- Statistical analysis, including multivariable logistic regression, was employed to identify associated factors.
Main Results:
- The prevalence of anti-HCV antibodies was 1.7%, and detectable HCV RNA was found in 1.4% of patients.
- HCV genotype 2 was identified in all patients with detectable viral load.
- Older age (>50 years) was significantly associated with anti-HCV reactivity (p<0.01).
- Elevated amylase levels were more common in patients with detectable HCV RNA (p=0.03), but liver enzymes were not significantly different.
Conclusions:
- HCV prevalence among HIV-infected patients in Bissau is low and comparable to other West African settings.
- The study confirmed the presence of HCV genotype 2 in the region.
- Age is a potential risk factor for HCV infection in this cohort, while clinical symptoms were not reliable indicators.
Objectives:
To estimate the prevalence and determine the clinical presentation of risk factors of hepatitis C virus (HCV) among HIV-infected patients in Bissau, Guinea-Bissau.
Methods:
In this cross-sectional study, we included individuals who had a routine blood analysis performed during the period April 28 to September 30, 2011. Patient samples were tested for HCV antibodies (anti-HCV) with a chemiluminescence test (Architect, Abbott, USA) and INNO-LIA HCV Score (Innogenetics, Belgium). HCV viral load and genotype were analyzed using an in-house real-time PCR method.
Results:
In total, 576 patients were included (417 HIV-1, 104 HIV-2, and 55 HIV-1/2). Ten (1.7%) patients were anti-HCV-positive and eight (1.4%) patients had detectable HCV RNA; all were genotype 2. In a multivariable logistic regression analysis, age >50 years was associated with anti-HCV reactivity (p<0.01). No subjective symptoms or objective signs were more prevalent among patients with detectable HCV RNA compared to patients without detectable HCV RNA. Biochemically, detectable HCV RNA was associated with elevated amylase (83.3% vs. 38.6%, p=0.03), but not with the liver enzymes alanine aminotransferase and aspartate aminotransferase.
Conclusions:
The prevalence of anti-HCV was low and comparable to similar settings, and genotype analysis confirmed the presence of genotype 2 in West Africa.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Sexually Transmitted Infections
Retrovirus Life Cycles
Cytomegalovirus Disease

